Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Notice to the Annual General Meeting of Cline Scientific AB

The shareholders of Cline Scientific AB, 556867-8238, ("Cline Scientific" or "the Company"), are hereby invited to the annual general meeting on Tuesday June 18, 2024 in the Company's premises at AstraZeneca BioVentureHub. Since passage into AstraZeneca's (AZ) premises requires registration, this and registration of shareholders takes place in AZ's main entrance between 16:15-16:30, Pepparedsleden 1, 43153 Mölndal. Information about the decisions made by the AGM will be published on 18 June 2024 via the AGM Kommuniqué.Right to participate and registration Anyone who is registered as a

Forbes 30 under 30 listed fashion designer duo Paolina Russo released its first SPINNOVA outfit at Challenge the Fabric

Award-winning Paolina Russo released their first outfit made with SPINNOVA® fibre at Challenge the Fabric event in Milan. The outfit shows that it is possible to create colourful and playful designs while being sustainable. Forbes 30 under 30 listed designer duo Paolina Russo released their first outfit made from a fabric containing sustainable SPINNOVA® fibre (21%) and cotton (79%). The denim-like fabric is woven in Finland, and it is dyed for example using natural pigments sourced from pine and indigo. The outfit was designed with the purpose of showing that sustainable

Kongsberg Automotive wins a new contract worth over EUR 13 million in estimated lifetime revenue

Kongsberg, May 16, 2024: Kongsberg Automotive (KA) has secured a new contract worth over EUR 13 million in estimated lifetime revenue for battery coolant pipes. The contract, awarded by a global Original Equipment Manufacturer (OEM) is for coolant pipes connected to a new generation of battery packs used in trucks. The manifold distributes coolant within the battery clusters in the truck’s battery cells and has a unique IP67 connection (water and dust tightness standard) to the truck’s chassis cooling system. For this three-year contract, KA will start production in 2025 and will

Year-end report 1 April 2023 - 31 March 2024

Fourth quarter (1 January - 31 March 2024) · Net sales amounted to SEK 5,091 million (5,267). · Operating profit before amortisation of intangible non-current assets (EBITA) increased by 1 percent and amounted to SEK 763 million (758) corresponding to an EBITA margin of 15.0 percent (14.4). · Operating profit amounted to SEK 649 million (660) corresponding to an operating margin of 12.7 percent (12.5). · Profit after tax amounted to SEK 451 million (461) and earnings per share before/after dilution amounted to SEK 1.60 (1.65). Full year (1 April 2023 - 31 March 2024) ·

Founders named European Inventor Award finalists

Faron Pharmaceuticals Oy   (“Faron” or the “Company”)     Faron founders and bexmarilimab developers selected as finalists for the European Inventor Award 2024   Press Release, May 16, 2024 at 9:00 (EEST) / 7:00 AM (BST) / 2:00 AM (EDT)     -          Dr. Markku Jalkanen and Dr. Sirpa Jalkanen, Faron’s co-founders, have been nominated as one of three finalists in the ‘SMEs’ category of prestigious European Patent Office Awards -          Nominated in recognition of research developing bexmarilimab, an investigational immunotherapy optimising clinical outcomes

Citycon divests Kongssenteret in Norway

CITYCON OYJ   Investor News   16 May 2024 at 9.00 hrsCitycon has signed an agreement to sell Kongssenteret in Kongsvinger, Norway. The sales price is close to the latest IFRS fair value of the asset. The transaction is estimated to close by the end of May.“The divestment follows Citycon’s strategy to focus on larger, grocery and municipal service-anchored urban hubs with direct connection to public transportation. The transaction showcases the attractiveness and desirability of necessity-based, inflation protected Nordic retail assets to investors as the transaction market is picking up”,

SUPERNOVA Trial Met COVID-19 prevention endpoint

16 May 2024 SUPERNOVA Phase III trial of sipavibart long-acting antibody met primary endpoints in preventing COVID-19 in immunocompromised patient population Positive high-level results from the SUPERNOVA Phase III COVID-19 pre-exposure prophylaxis (prevention) trial showed AstraZeneca's sipavibart (formerly AZD3152), an investigational long-acting antibody (LAAB), demonstrated a statistically significant reduction in the incidence of symptomatic COVID‑19 compared to control (tixagevimab/cilgavimab or placebo) in an immunocompromised patient population. The trial met both dual

Interim Report for 1st Quarter 2024

Revenues increased 15.46% and EBIT increased 4.41%Financial report for the period ended 31[st] March 2024 Key Facts for the 1[st] Quarter 2024 (1[st] January – 31[st] March 2024) Revenues increased 15.46% and EBIT increased 4.41% All figures are compared to the same quarter last year if not explicitly stated otherwise. · Revenues increased by 15.46 % to €10,885,611 (€9,428,231) · EBIT increased by 4.41% to €1,568,207 (€1,501,926) · EBIT margin of 14.41% (15.93%) · Net Profit of €824,927 (€1,136,073), decrease of 27.39% · Earnings per share of €0.0110 (€0.0152)

AcadeMedia publishes the Nomination Committee for the AGM 2024

In accordance with the principles adopted by the Annual General Meeting 2022, the Nomination Committee shall comprise one representative for each of the three largest shareholders based on ownership of the company as per the end of the financial year’s third quarter. Should one of the three largest shareholders refrain from appointing a representative to the Nomination Committee, the right shall pass to the shareholder that, excluding these three shareholders, has the largest shareholding in the company and wish to participate in the Nomination Committee. The chairman of the board shall be

Atlas Copco Group hosts Capital Market Day 2024

Nacka, Sweden, May 16, 2024: Atlas Copco Group hosts its Capital Markets Day in Belgium today. The purpose is to provide a run-through of the strategy and development of the Atlas Copco Group and its worldwide operations.The Capital Markets Day will provide participants with a more in-depth understanding of the Compressor Technique and Power Technique business areas and include presentations by the two Business Area’s Presidents as well as Vagner Rego, President and CEO and Peter Kinnart, CFO. The first part of the Capital Markets Day will be held in Mechelen and it will also be

TactoTek® Expands Operations in Japan, Wins Tokyo Metropolitan Government Subsidy for Green Transformation Technology

· TactoTek opens offices in Tokyo, Japan, to support licensees, OEMs, and brands. · Tokyo Metropolitan Government has awarded TactoTek a subsidy for green transformation technology. · TactoTek exhibits smart surface solutions at SusHi Tech Tokyo 2024.16th May 2024 - Oulu, Finland and Tokyo, Japan – Global smart surface technology leader, TactoTek[®] , today announced thhat the company has expanded its operations in Japan and formed TactoTek KK with offices in Tokyo, from which it will serve Japan and other Asia-Pacific markets. In conjunction with expanding its

Peab builds industrial building in Malmö

Peab has been commissioned to build an industrial building in eastern Malmö. The customer is Wihlborgs Fastigheter and the contract is worth SEK 166 million.The building will be located in the Fosie area and contain offices, warehousing and a processing industry for handling food. The total area will be 10,000 m² and divided into a part with one floor and a part with three floors. The building will be built according to Miljöbyggnad Gold and LFM30 requirements, which is a local initiative to develop a climate neutral construction and civil engineering sector in Malmö. "We are pleased and

Transaction in Own Shares

    16 May 2024 Vesuvius plc Share Buyback Programme – Transactions in Own Securities   Vesuvius plc (the "Company") announces that it has purchased the following number of its Ordinary Shares of 10p each from Jefferies International Limited (the “Broker”), pursuant to the terms of its Share Buyback Programme announced on 4 December 2023:   +---------------------------------------------------------------+----------+|Date of purchase: |15/05/2024|+---------------------------------------------------------------

Citycon improves its credit maturity profile by extending its revolving credit facility and two term loans

CITYCON OYJ   Investor News   16 May 2024 at 9.00 hrsCitycon has agreed with the lenders on a one-year extension of its EUR 650 million committed syndicated multicurrency credit facility by utilizing its one-year extension option. The facility consists of EUR 400 million revolving credit facility and a EUR 250 million term loan. The new maturity date for the facility is in April 2027. Additionally, Citycon has renegotiated the SEK 2,060 million term loan that was acquired with Kista Galleria and extended its tenor to five years. The term loan is now maturing in May 2029. “Extending

Ordinary Share Buyback: Transaction in Own Shares

16 May 2024 KR1 plc (“KR1” or the “Company”) Ordinary Share Buyback: Transaction in Own Shares KR1 plc announces that, on 15 May 2024, it purchased ordinary shares of 0.19p each in the Company ("Ordinary Shares") on the Aquis Stock Exchange through the Company's broker to the buyback, Singer Capital Markets Securities Limited, as set out below. Exchange Venue: Aquis Stock Exchange Number of Ordinary Shares purchased: 15,000 Highest price paid (per Ordinary Share): 79p Lowest price paid (per Ordinary Share): 74.65p Volume weighted average price paid (per Ordinary

Interim report Quartiers Properties January - March 2024

Quartiers Properties AB (publ) today publishes the company's interim report for the first quarter of 2024.EBITDA improved by 34% in the seasonally weak first quarter.   January - March 2024 · Revenue from operator activities totalled SEK 15,476 (13,581) thousand, corresponding to growth of 14%. · Income from the sale of properties during the period totalled SEK 13,963 thousand (44,570) and relates to the sale of three apartments in the Hacienda Collection. · Operating profit before depreciation and amortisation (EBITDA) amounted to SEK -5,754 thousand (-8,737), corresponding

Metacon publishes interim report for Q1 2024

We have successfully secured access to world-leading technology and partners for our efforts to become a leading manufacturer of large-scale, industrial electrolysis plants, comments Christer Wikner, President and CEO. For the full CEO-comment, see the Interim report in its entirety. Quarter 1 January–31 March · Revenues amounted to SEK 8.3 (16.3) million. · Earnings before depreciation and amortization (EBITDA) amounted to SEK -14.5 (-12.7) million. · Operating profit (EBIT) amounted to SEK -17.2 (-15.4) million. · Profit/Loss after financial items amounted to SEK -18.2

Sipiem - First Court Settlement

16 May 2024   Quantum Blockchain Technologies Plc (“ QBT” or the “Company”)     First Sipiem settlement and Acquisition of 30% of the claims collection rights   The Company is pleased to announce that the first preliminary settlement has been agreed between its wholly owned subsidiary, Clear Leisure 2017 Limited (“CL17”), and some of the Sipiem in Liquidazione S.r.l (“Sipiem”) case defendants.   Simultaneously, an agreement has been reached with Sipiem’s receiver (“Receiver”) to acquire its right to receive 30% of any sums collected, which was a provision of

Transcom Holding AB (publ): First quarter report 2024

Q1 2024 highlights · Revenue decreased to 189.1M€ (192.8) · EBITDA excluding non-recurring items decreased to 21.9M€ (25.5) · EBITDA margin excluding non-recurring items amounted to 11.6% (13.2%) · Operating cash flow amounted to 18.8M€ (17.9) · Net debt/EBITDA amounted to 4.0 (3.4) Comments by the CEO: Subdued start of the year, as expected Transcom's performance in the first quarter of 2024 was subdued as expected, with a slight decline in revenue of -1.9% (comparable organic development of -0.6% excluding exited business in Spain). EBITDA margin was 11.6%. While

FlexQubes report for the first quarter 2024

Press release 2024-05-16, 08:00 THE PERIOD 1 JANUARY – 31 MARCH 2023 · Net sales increased by 25.5 percent to 36.9 MSEK (29.4). Adjusted for foreign exchange rate effects between the comparison periods, net sales increased by 28.7 percent. · Order intake decreased by 14.8 percent to 30.5 MSEK (35.7). Adjusted for foreign exchange rate effects between the comparison periods, order intake decreased by 13.1 percent. · Operating profit before depreciation (EBITDA) amounted to -9.1 MSEK (-11.9) and operating profit before financial items (EBIT) amounted to -11.4 MSEK (-13.3). ·

Gympak accelerates in the Nordic region with sales director and large team

Clothing and tech company Gympak takes the next step in its growth journey by entering into a partnership agreement with Global Sales House and appointing Joachim Svensson to lead sales in the Nordic hotel market.The strategic decision aims to enable Gympak to not only focus on reaching new customers in other parts of the world but also to accelerate the development of innovative services and products. "Joachim brings with him extensive experience in sales and a deep commitment to customer relationships. He is passionate about developing both companies and businesses and will do

Judges and physicians have very different views about appointing a legal guardian for people with dementia

Published in the European Journal of Neurology, a new interdisciplinary study found weaknesses in guardianship assessment for people with dementia. The findings can be used to improve the consistency of medical and legal assessments, and to ensure equal treatment of those who may need legal guardianship.Dementia often leads to the appointment of a legal guardian for the individual affected, as their legal capacity diminishes as the disease progresses. Conducted in Finland, a recent study explored how physicians and legal experts perceive the association of the need for legal guardianship

There are no items matching the current filter
There are no more items matching the current filter
Back to top